- 1M
- 3M
- 6M
- 1YR
- 3YR
- 5YR
- 10YR
- Since Inception
Fund Information
-
As of 28 Feb 2025, fund size of Nippon India Pharma Fund is
6,891.31 Cr. -
Nippon India Pharma Fund shown here is of
Growthplan.
-
The Total Expense Ratio (TER) of the fund is
1.85%. The Total Expense Ratio (TER) is a measure that represents the total costs associated with managing and operating a mutual fund as a percentage of its average Assets under Management (AUM). It provides an insight into the overall expenses they will incur by investing in the fund.
-
Nippon India Pharma Fund is an
Equityoriented mutual fund in the
- Sectoral Fundcategory.
-
S&P BSE Healthcare TRI
is the benchmark for Nippon India Pharma Fund. A benchmark for a mutual fund serves as a standard for performance comparison, helping investors assess how well the fund is meeting its objectives and how it fares against relevant market indicators. Investors often compare the fund's performance with the benchmark as well as its peers.
-
The inception date of a mutual fund refers to the date when the fund was first established and began operations. It is the starting point from which the fund's performance, returns, and other key metrics are calculated. The fund was started on
01 Jun 2004as at present it is 21 years old fund.
-
Name of the AMC is
Nippon India Mutual Funds.
Click here to
know moreabout Nippon India Mutual Funds.
Fund Managed By
Fund managers make investment decisions, optimizing returns and managing risks for portfolios. Responsibilities include market analysis, performance monitoring. Nippon India Pharma Fund managed by following fund manager(s);
Riskometer
Investors understand that their
principal
will be at Very High risk
How does the
Return Comparison of the Nippon India Pharma Fund fare against peer funds in the Sectoral fund category?
Peer fund returns can vary based on the collaborative nature and specific strategies employed by fund managers of these funds listed in below table, often showcasing different risk-return profiles compared to strategy adopted by Nippon India Pharma Fund. Below table demonstrate the returns generated by some peer funds and compare tho this fund and average return generate by the Equity, Sectoral fund category these peer funds belongs to.
| Fund Name | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | 5 Years | 10 Years |
|---|---|---|---|---|---|---|---|---|
| Category Best | 13.68% | 10.31% | 6.46% | 21.90% | 36.56% | 31.82% | 40.30% | 17.44% |
| Category Average | 4.45% | 0.39% | -2.74% | 5.99% | 17.79% | 16.80% | 24.82% | 13.00% |
| Nippon India Pharma Fund | 3.83% | -2.41% | -5.75% | 13.96% | 30.52% | 20.94% | 21.86% | 14.08% |
| Franklin India Opportunities Fund | 6.69% | -1.01% | -5.14% | 9.09% | 36.33% | 31.82% | 32.65% | 15.58% |
| SBI PSU Fund | 3.19% | 3.50% | -6.63% | -3.00% | 35.85% | 30.85% | 31.75% | 12.67% |
| HDFC Infrastructure Fund | 4.42% | 1.62% | -7.23% | 1.20% | 33.29% | 30.14% | 36.29% | 10.84% |
| Invesco India PSU Equity Fund | 4.70% | 4.68% | -8.09% | -1.34% | 34.25% | 30.02% | 29.63% | 16.20% |
| Nippon India Power & Infra Fund | 5.25% | 1.55% | -8.91% | -1.09% | 30.02% | 29.39% | 35.42% | 16.18% |
Fund Portfolio Details
Portfolio details of a fund generally refer to a comprehensive breakdown of the investments held within a specific investment vehicle, such as a mutual fund or exchange-traded fund (ETF). Portfolio details of Nippon India Pharma Fund are shown below;
Equity 98.88%
Debt 0.00%
Others 1.12%
Top Equity Holdings
| Name of the Equity | Holding Percentage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 13.68% |
| DIVI'S LABORATORIES LTD. | 9.32% |
| LUPIN LTD. | 7.73% |
| CIPLA LTD. | 5.90% |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.14% |
| Others | 58.23% |
Allocation by Sector
| Name of the Sector | Holding Percentage |
|---|---|
| Healthcare | 95.49% |
| Consumer Services | 3.39% |
| N/A | 1.12% |
| Chemicals | 0.88% |
| Others | -0.88% |
Portfolio Holdings shown is as of 28 Feb 2025